← Back to Search

Fecal Microbiota Transplant

Fecal Microbiota Transplant (FMT) for Crohn's Disease

Phase 2
Waitlist Available
Led By Dina Kao, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8
Awards & highlights

Study Summary

This trial is testing if a series of fecal transplants can help improve Crohn's disease symptoms and if it is safe.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical and Endoscopic Remission
Secondary outcome measures
Clinical remission
Clinical response
Endoscopic remission
+4 more

Side effects data

From 2019 Phase 1 & 2 trial • 15 Patients • NCT02330653
17%
Non-Cardiac Chest Pain
17%
Abnormal Lab Values
17%
Grade 3 Colitis
17%
Eczema/Rash
8%
Sore Throat
8%
Upper Respiratory Infection
8%
Fever
8%
Epiploic Appendagitis
8%
Grade 3 Sinus Tachycardia
8%
Eye Disorder/Blurred Vision
100%
80%
60%
40%
20%
0%
Study treatment Arm
Fecal Microbiota Transplant (FMT)
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Fecal microbiota transplantExperimental Treatment1 Intervention
Transfer of healthy human gut bacteria
Group II: PlaceboPlacebo Group1 Intervention
Water
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fecal Microbiota Transplant (FMT)
2015
Completed Phase 2
~80

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,096 Total Patients Enrolled
University of CalgaryOTHER
792 Previous Clinical Trials
869,116 Total Patients Enrolled
McMaster UniversityOTHER
884 Previous Clinical Trials
2,598,278 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025